icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
The ASTRAL Studies: Evaluation of SOF/GS-5816 Single-Tablet
Regimen for the Treatment of Genotype 1-6 HCV Infection

 
 
  Reported by Jules Levin
EASL 2015 Vienna Austria
 
Tarik Asselah,1 Michael Charlton,2 Jordan Feld,3 Graham R. Foster,4 John McNally,5 Diana M. Brainard,5 John G. McHutchison,5 Alessandra Mangia,6 Mark Sulkowski,7 Stefan Zeuzem8
1University Paris Diderot, INSERM U773, Paris, France; 2Intermountain Medical Center, Murray, Utah, USA; 3Toronto Western Hospital, Toronto, Ontario, Canada; 4Queen Mary University of London, London, United Kingdom; 5Gilead Sciences, Inc., Foster City, California, USA; 6Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 7Johns Hopkins University, Baltimore, Maryland, USA; 8Johann Wolfgang Goethe University, Frankfurt, Germany

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

References
 
1. Jacobson IM, et al. New Engl J Med 2013;368:1867-77;
2. Lawitz E, et al. New Engl J Med 2013;368:1878-87;
3. Cheng G, et al. EASL 2013, poster 1191;
4. German P, et al. EASL 2013, poster 1195;
5. Lawitz E, et al. EASL 2013, poster 1082;
6. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02201940;
7. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02220998;
8. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02201953;
9. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02201901.